Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Pharmaceutical Quality Control Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The pharmaceutical quality control market has experienced swift growth in its size during recent times. This market is projected to expand from $8.23 billion in 2024 to $9.08 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this expansion has been driven by several factors, including heightened investments in pharmaceutical research and development, a greater frequency of drug recalls, an improved understanding of drug safety, the proliferation of testing protocols mandated by regulations, and an increase in the global exchange of pharmaceutical products.
The pharmaceutical quality control market is projected to experience swift expansion over the coming years. This market is predicted to reach $13.29 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.0%. The anticipated growth during this period stems from several factors, including the rising integration of artificial intelligence into quality control procedures, an expanding requirement for precision medicine evaluations, a greater call for superior medications, an escalating need for contract manufacturing solutions, and a growing insistence on real-time quality surveillance systems. Key trends anticipated during the forecast encompass progress in visual inspection systems driven by artificial intelligence, sophisticated microbial detection methods utilizing biosensors, the emergence of cloud-enabled quality control platforms, breakthroughs in real-time environmental monitoring technologies, and enhancements in digital twin technology for simulating processes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27380&type=smp
What Are The Key Drivers Of Growth In The Pharmaceutical Quality Control Market?
The increasing demand for biosimilars is anticipated to drive the expansion of the pharmaceutical quality control market moving forward. Biosimilars are defined as biologic medical products that exhibit high similarity to an already approved reference biologic, possessing no clinically significant differences in terms of safety, purity, and potency. This growing demand for biosimilars is primarily a consequence of patents expiring on original biologic drugs, thereby allowing more economical alternatives to enter the market. Pharmaceutical quality control ensures the safety, purity, and consistency of biosimilars through rigorous testing against reference biologics, consequently facilitating regulatory compliance and market approval. For instance, in January 2023, Cardinal Health Inc., a US-based healthcare company, reported that as of January 2022, there were 33 FDA-approved biosimilar products in the US, with 21 available on the market. By 2023, this figure had climbed to 40 FDA-approved biosimilars, with 25 commercially available. Therefore, the escalating demand for biosimilars is propelling the growth of the pharmaceutical quality control market.
What Are The Key Segments In The Pharmaceutical Quality Control Market?
The pharmaceutical quality control market covered in this report is segmented
1) By Product: Consumables, Services, Instruments
2) By Deployment Type: Cloud-Based And Web-Based, On-Premises
3) By Analysis Type: Sterility Testing, Membrane Filtration, Direct Inoculation, Bio Burden Testing, Aerobic Count Testing, Anaerobic Count Testing, Spore Count Testing, Fungi or Mold Count Testing, Endotoxin Testing, Other Analysis Types
4) By End-user: Pharmaceutical And Biotechnology Companies, Contract Development and Manufacturing Organization Or Contract Research Organization, Research Laboratories
Subsegments:
1) By Consumables: Culture Media, Reagents, Assay Kits, Filters And Membranes, Pipette Tips
2) By Services: Microbiological Testing Services, Analytical Testing Services, Stability Testing Services, Sterility Assurance Services, Validation And Qualification Services
3) By Instruments: Chromatography Systems, Spectroscopy Instruments, Particle Size Analyzers, Potential Of Hydrogen Meters And Electrical Conductivity Meters, Autoclaves And Incubators
How Are Emerging Market Trends Shaping The Pharmaceutical Quality Control Industry Landscape?
Major companies operating in the pharmaceutical quality control market are prioritizing technological advancements, such as intelligent software platforms, to enhance testing accuracy and regulatory compliance. Intelligent software platforms in pharmaceutical quality control represent sophisticated digital systems that leverage automation, data analytics, and artificial intelligence (AI) to improve the precision, efficiency, and conformity of testing processes. For instance, in June 2025, Dycine Pharmaceuticals Ltd., an India-based pharmaceutical company, launched an artificial intelligence-driven quality control platform designed to uplift manufacturing standards and ensure product integrity. This platform employs advanced artificial intelligence algorithms to identify anomalies, monitor real-time data, and streamline compliance procedures throughout the pharmaceutical production line. It offers essential features like predictive analytics, automated reporting, and seamless integration with existing manufacturing systems, thereby helping to reduce errors, boost efficiency, and maintain consistent quality across production batches.
Who Are The Major Companies Operating In The Pharmaceutical Quality Control Market?
Major companies operating in the pharmaceutical quality control market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, McKinsey And Company Inc., SGS S.A., Eurofins Scientific SE, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Mettler-Toledo International Inc., bioMérieux SA, Shimadzu Scientific Instruments Inc., Waters Corporation, Randox Laboratories Ltd., SOLVIAS AG, Esco Micro Pte. Ltd, REMI Elektrotechnik Limited, Lucideon Limited, and BRAM-COR S.p.A.
Download The Full Report For Exclusive Market Findings:
Which Region Is Expected To Witness The Fastest Growth In The Pharmaceutical Quality Control Market?
North America was the largest region in the pharmaceutical quality control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical quality control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Pharmaceutical Quality Control Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27380&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Quality Control Market 2025, By The Business Research Company
Handheld Laser Meter Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/handheld-laser-meter-global-market-report
Road Profile Laser Sensor Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/road-profile-laser-sensor-global-market-report
Laser Marking Machine Market 2025
https://www.thebusinessresearchcompany.com/report/laser-marking-machine-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model